AZ: Rescue plan?
From here.
AstraZeneca Plc (AZN) aims to advance at least eight medicines into late-stage tests within three years, one of its top research and development executives said today.
“We’ve set our R&D organization a goal of delivering eight to 11 Phase 3 projects,” Menelas N. Pangalos, executive vice president of the company’s Innovative Medicine Research Units, told reporters at a briefing in London
Well, the plans are very ambitious but clearly not realistical. Why AZ did not use the same plans earlier? And what have been changed in order to AZ could rely on these new plans in drug development and why these plans will be more successful than the previous ones? I would recommend to AZ to develop a plan B...
No comments:
Post a Comment